final project for given b

8/12/2019 Final Project for Given b

1/93

OBJECTIVES & PURPOSE

Objectives:

1. To Discover Whats !oi"# O"

To $ear" abo%t hat 'otivates s%rve( res)o"*e"ts a"* hats i')orta"t to the'.

+. To Provi*e ," O))ort%"it( To Disc%ss -e( To)ics With o%r Tar#et Po)%$atio" Toa$$os /orever i"si#ht i"to s%rve( )ro*%cts0 a"* ca" she* $i#ht o" to)ics re$ate* tose$$i"# & satis/actor( $eve$ e//ective"ess ithi" a $ar#er co"te2t.

3. To Provi*e a Be"ch'ar4 To )rovi*e a 5s"a)shot5 o/ tar#et )o)%$atio" a"* theirattit%*es abo%t s%rve( )ro*%cts. & To estab$ish a base$i"e /ro' hich e ca" co')arehether tar#et )o)%$atio" attit%*es a"* )erce)tio"s re$ative to the s%rve( )rob$e' are #etti"#better or orse over ti'e.

6. To chec4 o%t the re/$ect o/ the strate#ic objectives a"* #oa$s o/ or#a"i7atio".

8. To /i"* o%t That Whether there is a"( cha"#e or i')rove'e"t i" the )er/or'a"ce o/se$$i"# #roth o/ 'e*ici"es.

1


2/93

PURPOSE:

I" a ra)i*$( cha"#i"# societ(0 hea$th cari"# & *iste')er*ai$( ro%ti"e0is "ot o"$(acti"# that is *esirab$e b%t a$so a" activit( that a" or#a"i7atio" '%st co''it 9ar4et to0 i/ it isto 'ai"tai" a viab$e a"* 4"o$e*#eab$e or4 /orce. The s%rve( co"tai"s a "%'ber o/tech"i%es that ca" be %se* to )ro'ote a )ro*%ct ;or service< to a )ote"tia$ c%sto'er a"*

a$so estab$ish a"* 'ai"tai" a" active *ia$o#%e . 9ar4et s%rve( is a )rocess o/ $ear"i"#: ho to#ro %) a se%e"ce o/ )ro#ra''e* activities. It is a))$icatio" o/ i')rove'e"t & /%rther rise0b( #etti"# i"/or'atio" o/ the act%a$ )ositio" o/ /ir'=itse$/0 & o/ its co')etitors i" the 9ar4et.

The %estio" to be as4i"#0 co')i$e %se/%$ i"/or'atio" abo%t c%sto'ers ;$i4es0 *is$i4es0a"ts0 "ee*s a"* e2)ectatio"s< so that the co$$ate* i"/or'atio" ca" be $ater a"a$(se* a"* the/i"*i"#s %se* to i')rove o" /%t%re 'ar4eti"# ca')ai#"s0 services a"*or )ro*%cts.

-"o Retai$i"# Trac4i"# Service is To -"os %"i%e service0 to assist c$ie"ts to trac4 the sa$es )er/or'a"ce o/retai$i"# )ro*%cts b( a$$ co')etitio" bra"*s0 9ar4et s%rve(s )rovi*e acc%rate i"/or'atio" a"* a"a$(sis s%))ort /or c$ie"ts toi')rove the cha""e$ strate#(0 eva$%atio" a"* )ro'ote the sa$es )er/or'a"ce.

The s%ccess o/ those (o%"# a"* $ea*i"# co')a"ies $ies o" the /act that the( co%$* #ras) the 'i"or 'ar4et cha"#esver( %ic4$(The s%ccess o/ those /a'o%s co')a"ies ith $o"# histor( $ies o" the /act that the( co%$* ho$*the se"se o/ 'ar4et *eve$o)'e"t i" ti'eTo-"o Co"s%$ti"#0 o%$* $i4e to $ea* %s to *iscover those /acts0 e thi"4 'ore /or o%r c$ie"ts0 a"* ith 'ore actio" too??

Introduction to the Industry

2


3/93

The I"*ia" )har'ace%tica$ i"*%str( a**resses *o'estic a"* #$oba$ 'ar4ets thro%#h #oo*sa"* services that e"co')ass /i"ishe* *r%# *osa#es ;@or'%$atio"s


4/93

The I"*ia" )har'ace%tica$ i"*%str( a**resses the "ee*s o/ to broa* cate#ories o/ 'ar4et*o'estic a"* #$oba$.

Do'estic reve"%e is #e"erate* thro%#h sa$es a"* )ro'otio" o/ vario%s *r%# cate#ories.These i"c$%*e:K Ethica$ *r%#s ;avai$ab$e o"$( ith ritte" i"str%ctio"s /ro' a *octor to a )har'acist

!$oba$ !e"erics0 hich i"c$%*es bra"*e* a"* %"bra"*e* #e"erics>

Pro)rietar( Pro*%cts0 hich i"c$%*es Me Che'ica$ E"tities ;MCEs


10/93

!lobal Presence5

@oc%s o" US0 !er'a"(0 I"*ia a"* R%ssia

Who$$(=o"e* s%bsi*iaries i" the US,0 U-0 R%ssia0 Bra7i$0 Me Qea$a"*0 T%r4e( a"*9e2ico

Joi"t Ve"t%res i" Chi"a0 So%th ,/rica a"* ,%stra$ia

Re)rese"tative O//ices i" 1 co%"tries

3r* )art( Distrib%tio" set%)s i" +3 co%"tries

!oing *or=ard

@oc%s o" co"siste"t ear"i"#s & )ro/itab$e #roth

B%i$* $ea*ershi) )ositio" i" !$oba$ !e"erics a"* Phar'ace%tica$ Services & ,ctiveI"#re*ie"ts

1+


11/93

Create $evers o/ #roth /or /%t%re thro%#h Pro)rietar( Pro*%cts

BUSI&SS SUMMA(>

Dr. Re**(As Laboratories Li'ite*0 to#ether ith its s%bsi*iaries0 o)erates as a

)har'ace%tica$ co')a"(. The co')a"( /oc%ses o" /or'%$atio"s0 active )har'ace%tica$

i"#re*ie"ts a"* i"ter'e*iates0 #e"eric *r%#s0 critica$ care )ro*%cts0 biotech"o$o#( )ro*%cts0

11


12/93

c%sto' )har'ace%tica$ services0 a"* *r%# *iscover(. It co"*%cts research i" the areas o/

ca"cer0 *iabetes0 'etabo$ic *isor*ers0 car*iovasc%$ar *iseases0 i"/$a''atio"0 a"* bacteria$

i"/ectio". I" a**itio"0 the co')a"( i"vo$ves i" co"tract 'a"%/act%ri"# o/ #e"eric )rescri)tio"

a"* over=the=co%"ter )ro*%cts /or bra"*e* a"* #e"eric co')a"ies i" the U"ite* States.

Dr. Re**(As o//ers ce"tra$ "ervo%s s(ste'0 )ai" 'a"a#e'e"t0

#astroi"testi"a$0 res)irator(0 a"ti=i"/ective0 %ro$o#(0 o'e"As hea$th0 s)asticit(0 a"* a$i'e"tar(

tract re$ate* #e"erics /i"ishe* *osa#es. It 'ar4ets its )ro*%cts i" I"*ia0 R%ssia0 the U"ite*

States0 U"ite* -i"#*o'0 !er'a"(0 So%th ,/rica0 Bra7i$0 Chi"a0 -a7a4hsta"0 U7be4ista"0

U4rai"e0 Be$ar%s0 Viet"a'0 Ro'a"ia0 Ve"e7%e$a0 a"* 9(a"'ar. The co')a"( has a co=

*eve$o)'e"t a"* co''ercia$i7atio" a#ree'e"t ith De"'ar4 base* Rheoscie"ce ,S /or

the *eve$o)'e"t a"* co''ercia$i7atio" o/ Ba$a#$ita7o"eDR@ +830 a )artia$ PP,R=#a''a

a#o"ist /or the treat'e"t o/ t()e + *iabetes> a" a#ree'e"t ith C$i"Tec I"ter"atio"a$ /or the

*eve$o)'e"t o/ a" a"ti=ca"cer co')o%"*0 DR@ 16+> co$$aboratio" ith the Matio"a$ Ca"cer

I"stit%te i" 9ar($a"*> a" a#ree'e"t ith ,r#e"ta Discover( Li'ite* /or the joi"t *eve$o)'e"t

a"* co''ercia$i7atio" o/ a "ove$ a))roach to the treat'e"t o/ chro"ic obstr%ctive )%$'o"ar(

*isease> a"* a" a#ree'e"t ith HT9 Phar'a /or the *r%# *iscover( co$$aboratio" o"

se$ecte* *r%# tar#ets. Dr. Re**(As Laboratories Li'ite* as /o%"*e* i" 1G6 a"* is

hea*%artere* i" N(*eraba*0 I"*ia.

Integrated Business Model: TO B& MA"&3 $?@?

Inrastructure5

12


13/93

PSAI58 US*)A i"s)ecte* /aci$ities; i" I"*ia0 1 i" 9e2ico a"* 1 i" U- 3 Tech"o$o#(Deve$o)'e"t ce"ters ;+ i" I"*ia a"* 1 i" U- I)IA (USSIA O(T+ AM&(ICA

13


14/93

;ProductsSIS5

The overa$$ eva$%atio" o/ a co')a"( stre"#ths0 ea4"ess0 o))ort%"ities a"* threats is

ca$$e* SWOT a"a$(sis. It i"vo$ves 'o"itori"# the e2ter"a$ & i"ter"a$ 'ar4eti"# e"viro"'e"t.

The st%*( covers i"/or'atio" o" the b%si"ess str%ct%re

areas o/ o)eratio"0 )ro*%cts a"* services o//ere* b( the co')a"(. It co')rises SWOT

a"a$(sis0 -e( Ratios0 a"* /i"a"cia$s that ai* i"vestors i" #ai"i"# a" i"si#ht i"to the co')a"(s

)er/or'a"ce.

The re)ort is base* o" e2te"sive research %si"# *ata avai$ab$e /ro' cre*ib$e )%b$icatio"s

tra*e jo%r"a$s0 i"*%str( associatio"s a"* the co')a"( so%rces.

S$OT

STREN%TH $EANESS OPPO'NIT THREAT

($


77/93

Strength:-

Who$$( o"e* s%bsi*iaries i" US a"* E%ro)e

Joi"t ve"t%res i" Chi"a a"* So%th ,/rica9ar4ets )har'ace%tica$ )ro*%cts i" 118 co%"tries

Part"ershi)s ith #$oba$ )har'ace%tica$ co')a"ies $i4e Movartis0 MOVO Mor*is40 etc.

Stro"# )ro*%ct )ort/o$io

9a"%/act%re a"* 'ar4et over +8 'e*ici"es tar#eti"# a i*e ra"#e o/ thera)ies

Wi*e ra"#e o/ a"ti=ca"cer *r%#s *eve$o)e*

Over 1 ,PIs *eve$o)e*

Si2 Me Che'ica$ E"tities;MCE

Lo cost base

Co"trib%tes to co')a"(As hi#h )ro/it 'ar#i" o/ aro%"* 36F o/ sa$es

Part"ershi)s ith 4e( )$a(ers i" the 'ar4et 4ee)s its cost base *o"

Research Drive" & !$oba$ Ta$e"t

E2)ertise i" *eve$o)i"# i""ovative )ro*%ct /or'%$atio"s

1+ e')$o(ees or$*i*e i"c$%*i"# 81 scie"tists i" hich 3+3 are *e*icate* toar*s "e

*r%# *iscover( research

Other some special strength5

Ability to build D sustain Mega Brands

H bra"*s a'o"# To) 3 bra"*s

O'e7achieves sa$es o/ Rs 1 crs)er a""%'

Strong e0uity =ith !Ps @ CPs

88 HF o/ o%r To) 1 'o$ec%$es are )rescribe* b( !PsCPs

1F o/ !Ps CPs )rescribe 'ore tha" 6 o/ o%r )ro*%cts )er )rescri)tio"

Ability to establish ne= brands despite late launches in the market

((


78/93

Leo" ;3G8th ra"4


79/93

Weakness:-

Ni#h a'o%"t o/ reve"%es /ro' overseas I"*ia = a rich so%rce o/ ,ctive Phar'ace%tica$

I"#re*ie"ts ;,PIs he"ce the *e$a( i" the i')act o" the stoc4

)rice.< The case as /or the $a%"ch o/ a varia"t o/ P/i7ers b$oc4b%ster a"ti=h()erte"sive

Morvasc0 b( Dr. Re**(s.

The Dr. Reddy's stock, which had run up on expectations

that it would emerge successful in the on-going litigation with Pfizer, fell off a

cliff, shedding as much as Rs !! in intra-day trading. The sheer magnitude of

the drop is a reflection of the earnings upside factored into the stock price, as the

market had anticipated a positi"e outcome. The stock has since remained range-

#ound and now trades at a#out Rs $!$!.

(*


80/93

Figure 1: Stock performance of large-cap Pharma companies post Betapharm acquisition

Dr Re**(s si#"i/ica"t$( %"*er )er/or'e* its )eers as )ro/itabi$it( /ro' Beta)har'a co"ti"%e* to tre"* Do".

The stoc4 has %"*er)er/or'e* the broa*er 'ar4et a"* its )eers0 as the Beta)har',c%isitio" i" !er'a"( as hit b(: ;1< re#%$ator( cha"#e i" the !er'a" !e"erics9ar4et> a"* ;+< s%))$( iss%es /ro' the 4e( s%))$ier. Whi$e the $atter is bei"# ,**resse* b(Dr Re**(As0 a"* 'ore )ro*%ctio" has bee" shi/te* to I"*ia0 the Re#%$ator( cha"#e has'ea"t that the !er'a" !e"erics 'ar4et is "o c$oser to the US #e"eric 'ar4et ;$oer'ar#i"s0 'ore co')etitio"0 a"* re*%ce* bra"* a*va"ta#e< ,"* 'ar#i"s co%$* str%ct%ra$$(co'e *o"

Table $5 Core business P@& or ma:or pharma companies

"ey risks5

Shar) s$o*o" i" bra"*e* #e"erics 'ar4ets.

Co"ti"%e* ea4"ess i" !er'a" #e"erics 'ar4et

The co')a"( )%rs%i"# ac%isitio"s eve" as Beta)har' has "ot (et stabi$i7e*

)+


81/93

Opportunities:-

;AboutCore business P@& or ma:or pharma companies in Table 6S&5 ()>

#&Jhibit 95 Market Share and !ro=th (ate o "ey Players in the Indian PharmaceuticalIndustry

E2hibit 6 = shos that the 4e( )$a(ers o/ the I"*ia" )har'ace%tica$ 'ar4et are !S"(anbaJy Cipla icholas Piramal ,ydus Cadila Sun Pharma Alkem PiKer Lupinand )(L- These te" co')a"ies acco%"t /or a 'ar4et share o/ 3.F. !S-0 the $ar#est

)$a(er0 co"trib%tes 8.+F0 /o$$oe* b( Ra"ba2( ;8.1F< a"* Ci)$a ;8.1F


87/93

*indings5

,/ter the a"a$(sis o/ co')a"( & a$$ the *ata0 the co"c$%sio" is i')orta"t that there are 'a"(

barriers a"* h%r*$es betee" i" the se$$=b%( cha""e$ "etor40 so the c%sto'er %"satis/ie* to

the 'e*ici"e0 beca%se the 'e*ici"e "ot /%$/i$$i"# the satis/actio" accor*i"# to there hea$th=

*e'a"*.

The /o$$oi"# so'e /i"*i"#s o/ so'e are shoi"# this state'e"t:

6. In Shastri agar area0 There are 61 Stri) is the 'a2i'%' %a"tit( o/ 'e*ici"e= ,tor$i)

;Ci)$a< & ,tocor is /o%"* abse"t i" 'o$ec%$e= ,torvastati".

I" Te$'isarta" 'o$ec%$e0 3 Stri) is the 'a2i'%' %a"tit( o/ 'e*ici"e= Te$'a 9 &

Te$sarta" is /o%"* abse"t.

+ I"(a:apark areaThere are H stri)s is the 'a2i'%' %a"tit( o/ 'e*ici"e=

,torva & 1 stri) is o/ ,tocor i" 'o$ec%$e ,torvastati".

I" Te$'isarta" 'o$ec%$e0 181 stri)s is the 'a2i'%' %a"tit( o/ 'e*ici"e= Te$'a N &

stri)s are o/ Te$ssarta".

3 In Mal1iya agar area0 There are 33 stri) is the 'a2i'%' %a"tit( o/ 'e*ici"e=

,torva & 6 stri)s are o/ ,tocor i" 'o$ec%$e= ,torvastati".

I" Te$'isarta" 'o$ec%$e0 3G+ stri)s is the 'a2i'%' %a"tit( o/ 'e*ici"e= Te$'a N & 1

stri)s are o/ Te$ssarta"

)(


88/93

6. In Aadarsh agar areaThere are 111 stri)s is the 'a2i'%' %a"tit( o/ 'e*ici"e=

,torva & 8 stri)s o/ ,tocor i" 'o$ec%$e ,torvastati".

I" Te$'isarta" 'o$ec%$e018 stri)s is the 'a2i'%' %a"tit( o/ 'e*ici"e Te$'a N & H


In SMS area0 There are +H stri)s is the 'a2i'%' %a"tit( o/ 'e*ici"e=


I" Te$'isarta" 'o$ec%$e0 1+H stri)s is the 'a2i'%' %a"tit( o/ 'e*ici"e Te$'a & 3H stri)s

are o/ Te$ssarta"

N. In "hatipurahot=ara area0 There are +8 stri)s is the 'a2i'%' %a"tit( o/ 'e*ici"e=

,tor$i) ;Ci)$a< & 3 stri)s are o/ ,tocor i" 'o$ec%$e=,torvastati".

I" Te$'isarta" 'o$ec%$e01 stri)s is the 'a2i'%' %a"tit( o/ 'e*ici"e= Te$'a & 8o stri)s

are o/ Te$sarta".

In C Scheme area0 There are 381 stri)s is the 'a2i'%' %a"tit( o/ 'e*ici"e=Storvas & 8

stri)s are o/ ,tocor i" 'o$ec%$e= ,torvastati".

I" Te$'isarta" 'o$ec%$e0 81 stri)s is the 'a2i'%' %a"tit( o/ 'e*ici"e= Te$'a & 1G


))


89/93

8 In 4aishali agar area0 There are 18 stri)s is the 'a2i'%' %a"tit( o/ 'e*ici"e= ,torva

& 3H stri)s are o/ ,rtocor i" 'o$ec%$e=,torvastati".

I" Te$'isarta" 'o$ec%$e0 1H stri)s is the 'a2i'%' %a"tit( o/ 'e*ici"e= Te$'a N &

Te$ssarta" is /o%"* abse"t.

7 In ohri BaKar area0 There are ++1 stri)s is the 'a2i'%' %a"tit( o/ 'e*ici"e=

,torva & H stri)s are o/ ,tocor i" 'o$ec%$e=,torvastati".

I" Te$'isarta" 'o$ec%$e0 1H stri)s is the 'a2i'%' %a"tit( o/ 'e*ici"e= Te$'a & G

stri)s are o/ Te$sarta".

6F In Santokba )urlabh:i Memorial +ospital areaThere are 11 stri)s is the 'a2i'%'

%a"tit( o/ 'e*ici"e= ,torva & stri)s are o/ ,tocor i" 'o$ec%$e= ,torvastati".

I" Te$'isarta" 'o$ec%$e0 +8 stri)s is the 'a2i'%' %a"tit( o/ 'e*ici"e=Te$'a & 3 stri)s

are o/ Te$ssarta".

6F- In Sanganer areaThere are 138 stri)s is the 'a2i'%' %a"tit( o/ 'e*ici"e=

,torva & 8 stri)s are o/ ,tocor i" 'o$ec%$e=,torvastati".

I" Te$'isarta" 'o$ec%$e0 8 stri)s is the 'a2i'%' %a"tit( o/ 'e*ici"e= Te$'a N &

Te$ssarta" is /o%"* abse"t.

)*


90/93

66 In Mansaro1ar area0 I" There are +6 stri)s is the 'a2i'%' %a"tit( o/ 'e*ici"e=

,torva & 3 stri)s are o/ ,tocor i" 'o$ec%$e=,torvastati".

I" Te$'isarta" 'o$ec%$e0 +H3 stri)s is the 'a2i'%' %a"tit( o/ 'e*ici"e= Te$'a & 1

stri)s are o/ Te$ssarta"

6$- In 4idhyadhar agar area0 There are 3 stri)s is the 'a2i'%' %a"tit( o/ 'e*ici"e=


I" Te$'isarta" 'o$ec%$e0 There are 3 stri)s is the 'a2i'%' %a"tit( o/ 'e*ici"e=Te$'a N

& Te$ssarta" is /o%"* abse"t.

Th%s0 c%sto'ers accor*i"# to their taste o/ hea$th0 *e'a"*s ,torva: Te$'a as the best

satis/actio" 'e*ici"e )re/erab$(0 hi$e0 ,tocor & Te$sarta"As )ositio" is bei"# %"*er it

*+


91/93

Conclusion5

I" jai)%r cit(0 9e*ici"e bra"*s o/ vario%s t()es0 are estab$ishi"# /ast$(0 ith

i"creasi"# the Nea$th=)rob$e's & other *iseases0 as the Jai)%r cit( is #oi"# toar*s The

9etro)o$ita" Cit(. O%t o/ the' are o/ Ci)$a0 Ra"ba2(0 Q(*%s Ca*i$a0 Dr re**(As0 L%)i"

Torre"t0 ,risto or S%" Phar'ace%tica$s.

I" these0 Dr re**(As to bra"*s= ,tocor & Te$sarta" i" 'o$ec%$e : ,torvastati"

& Te$'isarta" ith co'bi"atio" o/=Amlodipine&N(*roch$orothia7i*e are "ot #etti"#

ho$e catch %) /ro' 9ar4et *e'a"*. Acorse These to bra"*s ha* #ot

reor#a"i7atio" /ro' Phar'ace%tica$ sector i" the )ast. Th%s these are s%bject o/

%estio"0 That ho the( are Deve$o)i"# i" )rese"t ti'e What is 'otive )oer0

hich is or4i"# /or Estab$ish'e"t o/ this bra"*s=)ro*%ct @ro' here these

'e*ici"es are "ot #etti"# )rescri)tio" & h( No '%ch is the trai"i"# & e*%catio"a$

%a$i/icatio" o/ the or4i"# )erso"a$s i" the re$ate* *e)art'e"t0 ho are E"#a#e i"

)ro'ote to these Which are the *istrib%tio" /aci$ities )rovi*es to the retai$ers b( the

that *e)art'e"t o/ the co')a"( Etc. To /i"* o%t the a"sers to these %estio"s0 the

researcher has st%*ie* the se$$i"# o/ the Phar'ace%tica$ )ro*%cts o" 9e*ica$ sho)s.

*1


92/93

(ecommendation and Suggestions5

The co"tacte* Retai$ers *%ri"# the trai"i"#0 o//ere* vario%s s%##estio" so as to %)raise

the c%rre"t )ositio" o/ ,tocor & Te$sarta" i" the *o'estic )har'ace%tica$ 'ar4et.

The suggestions are gi1en5

,$tho%#h se$$i"# rate at Dr re**(As have bee" /o%"* e//ective i" so'e areas0 b%t

to 'a4e these rate 'ore e//ective0 a$$ the thi"#s *isc%sse* above '%st #et i"to care o/ /ro'

"o o"ar*s. ,/ter i')$e'e"ti"# a$$ the re%ire* cha"#es0 I a' s%re> co')a"( i$$ /i"*

9,R-ET SURVE as the best TOOL /or bri"#i"# a$$ the re%ire* cha"#es i" the co')a"(

/or the *eve$o)'e"t.

*2


93/93

Bibliography

.*rre**(s.co'

.*r%#s%)*ate.co'

.'e*ici"e.co'

."se.co'

9ar4eti"# s%rve(

Data co$$ocatio" /ro' 'e*ica$ sho)s.

9eeti"# Dr. o/ S.9.S Nos)ita$ ;Dr.C.L Maa$0Dr.!.M Sa2e"a0< ithMr-4arun Shri1ast1a ;M-(

final project for given b

Documents